Schedule 13G Filing for vTv Therapeutics Inc. by Invus Public Equities and Related Entities

The Schedule 13G filing reports the beneficial ownership of Class A Common Stock of vTv Therapeutics Inc. by Invus Public Equities, L.P., and related entities. As of August 29, 2025, the Reporting Persons collectively beneficially owned 348,083 shares, representing 9.99% of the issued and outstanding shares. The filing includes detailed information on the ownership structure, with Invus Public Equities directly holding 143,440 shares and warrants, and Avicenna Fund directly holding 19,560 shares and warrants. The filing also outlines the relationships between the various entities and individuals, including Raymond Debbane, who controls several of the entities. The Reporting Persons certify that the securities were not acquired for the purpose of influencing the control of the issuer.